Using observational analysis of multiple sclerosis relapse to design outcomes-based contracts for disease-modifying drugs: a feasibility assessment.

Lage, Maureen J

Using observational analysis of multiple sclerosis relapse to design outcomes-based contracts for disease-modifying drugs: a feasibility assessment. [electronic resource] - Journal of medical economics Sep 2013 - 1146-53 p. digital

Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't

1941-837X

10.3111/13696998.2013.823868 doi


Adolescent
Adult
Antibodies, Monoclonal, Humanized--economics
Cohort Studies
Confidence Intervals
Contracts--economics
Feasibility Studies
Female
Hospitalization--economics
Humans
Immunosuppressive Agents--economics
Insurance Claim Review--economics
Interferon-beta--economics
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting--diagnosis
Natalizumab
Observation--methods
Odds Ratio
Outcome Assessment, Health Care--economics
Poisson Distribution
Predictive Value of Tests
Prognosis
Recurrence
Retrospective Studies
Risk Management
Severity of Illness Index
Time Factors
Treatment Outcome
Young Adult